Recurrent Tuberculosis

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Recurrent Tuberculosis trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 3

NCT06727864

Short Course Regimen in Low Risk Active Tuberculosis- a Multicenter, Randomized, Active-controlled, Trial

Tuberculosis remains an important global health problem, and the world is currently not on track to end the TB epidemic by 2030. With the concerted efforts of t…

Taiwan270 participantsStarted 2024-01-01

Treatment: 4-month regimen (2HERZ/2HRE), 6-month (2HERZ/4HRE)

All recent trials (13 shown)

CompletedPhase 2

NCT03512249

Study to Evaluate H56:IC31 in Preventing Rate of TB Recurrence

This is a phase 2, double-blind, randomized (1:1), placebo-controlled trial with two parallel groups. * H56:IC31 (investigational vaccine) * Placebo 900 HIV…

South Africa831 participantsStarted 2019-01-31

Treatment: H56:IC31, Placebo

Not Yet RecruitingPhase 3

NCT07136987

A Trial of 2 Disease-Modifying Drugs (Metformin and N-acetylcysteine ) to Promote TB Lung Function Recovery

Tuberculosis is a leading global cause of morbidity and mortality. Even if cured, a majority patients are left with bronchiectasis and fibrosis, permanent condi…

Location not specified1,104 participantsStarted 2026-01

Treatment: Metformin, N-Acetylcysteine (NAC) Treatment

Recurrent Tuberculosis

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Short Course Regimen in Low Risk Active Tuberculosis- a Multicenter, Randomized, Active-controlled, Trial

All recent trials (13 shown)

Study to Evaluate H56:IC31 in Preventing Rate of TB Recurrence

A Trial of 2 Disease-Modifying Drugs (Metformin and N-acetylcysteine ) to Promote TB Lung Function Recovery

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Short Course Regimen in Low Risk Active Tuberculosis- a Multicenter, Randomized, Active-controlled, Trial

All recent trials (13 shown)

Study to Evaluate H56:IC31 in Preventing Rate of TB Recurrence

A Trial of 2 Disease-Modifying Drugs (Metformin and N-acetylcysteine ) to Promote TB Lung Function Recovery

Tuberculosis (TB) Aftermath

Study to Check the Efficacy and Safety of Recombinant BCG Vaccine in Prevention of TB Recurrence

Four Months Moxifloxacin Containing Daily Regimen Study Among New Pulmonary Tuberculosis Patients

Short Course Rifapentine and Isoniazid for the Preventive Treatment for Latent Genital Tuberculosis

Vitamin D to Resolve Inflammation After Tuberculosis (ResolveD-TB)

Improving Retreatment Success (IMPRESS)

Multi-Drug Resistant Tuberculosis in Korea

Pimonidazole Hydrochloride to Detect Low Oxygen in Tuberculosis-Infected Lungs

Tuberculosis Recurrence Upon Treatment With Highly Active Antiretroviral Therapy

Exogenous Reinfection of Tuberculosis in Taiwan